< E837E839389EF8E8F39328AAA348D862E706466>
|
|
|
- れいな みょうだに
- 5 years ago
- Views:
Transcription
1 2 92 9:0 0:0 :5 :00 :00 :5 :5 :0 :0 :5 :5 5:20 5:20 6:5 6:5 6:25 6:25 6:0 6:0 7:0 7:0 7:0 I F05 9:0 0:25 -I- II F02 9:0 0:25 -II- III 2F 9:0 0:25 -III- 0:25 :0 0:25 :0 0:25 :0 -I-5 8 -II-5 8 -III-5 8 :0 :55 :0 :55 :0 :55 -I-9 2 -II-9 2 -III-9 2 2:05 :00 2:05 :00 DSM 8:00 20:00
2 208 9:0 :0 I :5 :5 :5 :5 Manfred Eggersdorfer :5 6:0 II I F05 II F02 III 2F 9:0 0:25 2-I- 9:0 0:25 2-II- 9:0 0:25 2-III- 0:25 :0 2 -I-5 8 :0 :55 2-I-9 2 2:05 :00 2:05 :00 :0 5:5 2 -I- 6 5:5 5:50 2 -I-7 9 0:25 :0 2-II-5 8 :0 :55 2-II-9 2 :0 5:5 2 -II- 6 0:25 :0 2-III-5 8 :0 :55 2-III-9 2 :0 5:5 2 -III- 6 5:5 6:00 5:5 6:00 2 -II III-7 20 F II USB
3 Windows PowerPoint USB 2 Mac VGA : VGA
4 :0 0:0 D PET :5 :00 :00 :0 :00 :5 JCHO :5 :0 :0 :5 :5 5:20 :5 5:00 E K 5:00 5:5 B2 5:20 6:5 5:20 5:5 5:5 6:0
5 6 92 6:5 6:25 6:25 6:0 6:0 7:0 7:0 7:0 : 8:00 20: :0 0: B6 2 2,2,2,2, B C :25 : Univ. Exeter Biosci. 2 Mike Page Nicholas Smirnoff - -6 vtc 2 2, - -7
6 C ODS :0 : LED I NAD NAD 2:05 :00 E :0 0: D Hydroxyvitamin D vitamin D 25-hydroxyvitamin D University of Miami Department of Biochemistry and Molecular Biology Tufts University Vascular Biology Lab Jean-MarcZingg MohsenMeydani AngeloAzzi 5,6
7 8 92 0:25 : PCOOH PCOOH E 2 5 2, Elovl5 2,2, thode 2, ,2 :0 : ,2, - -0 STAT - - APXII 2 2,2, VTC2 2 2,2,2 2:05 :00 DSM Personalized Nutrition
8 :0 0: , , OCARINA 2 2, :25 : L- L Se - -7 D Bacillus smithii FMN-NADH 2 2 :0 : Rasamsonia emersonii YA D L FAD L- 2,2, Sulfolobus tokodaii NAD 2 2
9 :0 :0 9:0 0:00 SSCI 0:00 0:0 0:0 :00 :5 :5 :5 :5 Perspectives for vitamins (and other nutrients) for a healthy life Manfred Eggersdorfer DSM Professor for Healthy Ageing University Medical Center Groningen :5 6:0 :20 :5 D :5 5:0 5:0 5:5 : 5:5 6:00 6:00 6:25 B
10 :0 0: tocotrienol 2, tocopherol PGC :25 : CoQ0 DNA choline in vivo 2 5 Thanutchaporn Kumrungsee ,2,2 2,5 :0 : B B2 Caenorhabditis elegans 2- - B6 2 Thanutchaporn Kumrungsee 2 Dwi Eva Nirmagustina
11 Zn 2, :05 :00 D :0 5: D CYP27B D , VCRESC 2 2 5:5 5: Euglena gracilis 2,2,, BPD C
12 :0 0: D enhancer RNA 2 5,2,2, 5 5, K L Ca Vitamin K2 attenuates LPS-induced inflammation in mouse microglial cells WAHYU DWI SAPUTRA NAO AOYAMA HITOSHI SHIRAKAWA MICHIO KOMAI - PXR Sultana Halima 0:25 : Lipo- 2 AMED-CREST,2,2, AMED-CREST,2,2, SMS2 2 AMED-CREST,2,2,2, SAMP :0 : K K K K 2 2
13 K 2 2 2:05 :00 :0 5: RXR , 25- D 2 AMED-CREST AMED -,2 2,, D :5 6: Adamantyl- 25-dihydroxyvitamin D 2 University of Santiago de Compostela Spain Rocio Otero 2 Antonio Mourino Turn-On D H- 9Z
14 :0 0: N- 2 Zahir Hussain 2 Smriti Sultana Binte Mustafiz, C RhoA ADP CYPB 0:25 : K UBIAD UBIAD D D VDR 25 OH D D :0 : VDR D CYP2A 25- D 2 2 2
15 D :0 5: CRISPR/Cas9 B2 2, C ODS ,2,2 5:5 6: B2 Caenorhabditis elegans Lactobacillus brevis KB290 A BDHQ D 2, B 2 2 2,2,2
< E837E839389EF8E8F39318AAA31328D862E706466>
Vol. 91 2017 29 12 12 2017 91 1 1 8 1 1 B1 B2 B6 B12 1 2 2 C 87 5 6 323 1-1 D 28 1-2 38 2-1 VDR 113 2-2 A 121 3-1 D 165 7-1 FAD, PLP NAD 403 8-1 E 469 8-2 D3 480 12-1 NAD P 677 1-1 173 1-2 D 174 1-3 E
I? 3 1 3 1.1?................................. 3 1.2?............................... 3 1.3!................................... 3 2 4 2.1........................................ 4 2.2.......................................
20 15 14.6 15.3 14.9 15.7 16.0 15.7 13.4 14.5 13.7 14.2 10 10 13 16 19 22 1 70,000 60,000 50,000 40,000 30,000 20,000 10,000 0 2,500 59,862 56,384 2,000 42,662 44,211 40,639 37,323 1,500 33,408 34,472
- 2 -
- 2 - - 3 - (1) (2) (3) (1) - 4 - ~ - 5 - (2) - 6 - (1) (1) - 7 - - 8 - (i) (ii) (iii) (ii) (iii) (ii) 10 - 9 - (3) - 10 - (3) - 11 - - 12 - (1) - 13 - - 14 - (2) - 15 - - 16 - (3) - 17 - - 18 - (4) -
2 1980 8 4 4 4 4 4 3 4 2 4 4 2 4 6 0 0 6 4 2 4 1 2 2 1 4 4 4 2 3 3 3 4 3 4 4 4 4 2 5 5 2 4 4 4 0 3 3 0 9 10 10 9 1 1
1 1979 6 24 3 4 4 4 4 3 4 4 2 3 4 4 6 0 0 6 2 4 4 4 3 0 0 3 3 3 4 3 2 4 3? 4 3 4 3 4 4 4 4 3 3 4 4 4 4 2 1 1 2 15 4 4 15 0 1 2 1980 8 4 4 4 4 4 3 4 2 4 4 2 4 6 0 0 6 4 2 4 1 2 2 1 4 4 4 2 3 3 3 4 3 4 4
1 (1) (2)
1 2 (1) (2) (3) 3-78 - 1 (1) (2) - 79 - i) ii) iii) (3) (4) (5) (6) - 80 - (7) (8) (9) (10) 2 (1) (2) (3) (4) i) - 81 - ii) (a) (b) 3 (1) (2) - 82 - - 83 - - 84 - - 85 - - 86 - (1) (2) (3) (4) (5) (6)
NAD11 00 1 1-1 1-2 1-3 5V 1-4 1 2 3 4 5 6 7 8 1 2 3 4 5 6 1-5 1 2 3 1 2 3 4 1-6 1 2 3 1-7 1-8 1 2 3 4 5 6 7 8 1 2 3 4 5 6 7 1 2 3 4 5 6 7 8 9 10 11 1 2 3 4 5 1 2 3 4 5 1
土木工事の
.1 ... 2 -...2 -...3 -...4 -...5 -...7... 8 -...8 -...9... 10 -... 10 -... 13 -... 14... 17 -... 17... 19... 19... 24... 24... 26 -... 26... 27... 27... 29... 30... 31 -... 31 -... 33 -... 35 1 1 2 3 4
44 4 I (1) ( ) (10 15 ) ( 17 ) ( 3 1 ) (2)
(1) I 44 II 45 III 47 IV 52 44 4 I (1) ( ) 1945 8 9 (10 15 ) ( 17 ) ( 3 1 ) (2) 45 II 1 (3) 511 ( 451 1 ) ( ) 365 1 2 512 1 2 365 1 2 363 2 ( ) 3 ( ) ( 451 2 ( 314 1 ) ( 339 1 4 ) 337 2 3 ) 363 (4) 46
2016.05月号cs5.indd
5 2016.5.1 2 3 2016.5.1 2016.5.1 4 5 2016.5.1 2016.5.1 6 2016.5.1 7 2016.5.1 8 2016.5.1 9 2016.5.1 10 11 2016.5.1 2016.5.1 12 2016.5.1 13 Healthy 2016.5.1 14 2016.5.1 15 Healthy 2016.5.1 16 2016.5.1 17
i ii i iii iv 1 3 3 10 14 17 17 18 22 23 28 29 31 36 37 39 40 43 48 59 70 75 75 77 90 95 102 107 109 110 118 125 128 130 132 134 48 43 43 51 52 61 61 64 62 124 70 58 3 10 17 29 78 82 85 102 95 109 iii
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 () - 1 - - 2 - - 3 - - 4 - - 5 - 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57
１
10 1113 14 1516 1719 20 21 22 2324 25 2627 i 2829 30 31 32 33 3437 38 3941 42 4344 4547 48 4950 5152 53 5455 ii 56 5758 59 6061 iii 1 2 3 4 5 6 7 8 9 10 PFI 30 20 10 PFI 11 12 13 14 15 10 11 16 (1) 17
VITAMIN-89-12_R23058(高解像度).pdf
Vol. 89 2015 27 1 89 89 1 3 97 1 E 1 1 E in vitro in vivo 19 3 E 108 7 B6 327 10 A 471 11-1 511 11-2 C 528 12 E 561 2-1 59 2-2 65 2-3 D 72 5 6 275 9 441 392 8-1 393 8-2 397 2-1 53 2-2 -4 56 3 116 12 12
Exif Viewer, DPOF Editor 使用説明書
Exif Viewer DP Editor 2 3 I 4 II III 5 I 6 I 7 I 8 I 9 I 10 I 11 I 12 I 13 I 14 I 15 I 16 I 17 I 18 I 19 I 20 I 21 I 22 I 23 I 24 25 I 26 I 27 I 28 I 29 I Windows 30 I 31 I 32 I 33 I 34 35 II II 36 II
（個別のテーマ） 薬剤に関連した医療事故
- 67 - III - 68 - - 69 - III - 70 - - 71 - III - 72 - - 73 - III - 74 - - 75 - III - 76 - - 77 - III - 78 - - 79 - III - 80 - - 81 - III - 82 - - 83 - III - 84 - - 85 - - 86 - III - 87 - III - 88 - - 89
（個別のテーマ） 放射線検査に関連した医療事故
- 131 - III - 132 - - 133 - III - 134 - - 135 - III - 136 - - 137 - III - 138 - - 139 - III - 140 - - 141 - III - 142 - - 143 - III - 144 - - 145 - III - 146 - - 147 - III - 148 - - 149 - III - 150 - -
EV200R I II III 1 2 3 4 5 6 7 8 9 10 1 2 3 11 4 5 12 6 13 1 2 14 3 4 15 5 16 1 2 17 3 18 4 5 19 6 20 21 22 123 456 123 456 23 1 2 24 3 4 25 5 3 26 4 5 6 27 7 8 9 28 29 30 31 32 1 2 33 3 4 34 1 35 2 1
訪問看護ステーションにおける安全性及び安定的なサービス提供の確保に関する調査研究事業報告書
1... 1 2... 3 I... 3 II... 3 1.... 3 2....15 3....17 4....19 5....25 6....34 7....38 8....48 9....58 III...70 3...73 I...73 1....73 2....82 II...98 4...99 1....99 2....104 3....106 4....108 5.... 110 6....
untitled
. -28- 1 1 2-29- 11 USB -30- -31- -32- -33- -34- 11-35- 3-36- -37- 2-38- -39- -40- -41- -42- 11-43- -44- -45- 3-46- -47- 11-48- 1-49- -50- -51- -52- -53- -54- 1-55- 1 3-56- -57- -58- 11-59- -60- -61- 1-62-
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 ( ) 24 25 26 27 28 29 30 ( ) ( ) ( ) 31 32 ( ) ( ) 33 34 35 36 37 38 39 40 41 42 43 44 ) i ii i ii 45 46 47 2 48 49 50 51 52 53 54 55 56 57 58
untitled
i ii (1) (1) (2) (1) (3) (1) (1) (2) (1) (3) (1) (1) (2) (1) (3) (2) (3) (1) (2) (3) (1) (1) (1) (1) (2) (1) (3) (1) (2) (1) (3) (1) (1) (1) (2) (1) (3) (1) (1) (2) (1) (3)
23 15961615 1659 1657 14 1701 1711 1715 11 15 22 15 35 18 22 35 23 17 17 106 1.25 21 27 12 17 420,845 23 32 58.7 32 17 11.4 71.3 17.3 32 13.3 66.4 20.3 17 10,657 k 23 20 12 17 23 17 490,708 420,845 23
平成１８年度「商品先物取引に関する実態調査」報告書
... 1.... 5-1.... 6-2.... 9-3.... 10-4.... 12-5.... 13-6.... 15-7.... 16-8.... 17-9.... 20-10.... 22-11.... 24-12.... 27-13... 29-14.... 32-15... 37-16.... 39-17.... 41-18... 43-19... 45.... 49-1... 50-2...
QW-3414
MA1312-C P 1 2 3 A E L D E D A A E D A D D D D D E A C A C E D A A A C A C A C E E E D D D A C A C A A A A C A C A C E E C C E D D C C C E C E C C E C C C E D A C A C A C E L B B
Page 1
Page 1 Page 2 Page 3 Page 4 620 628 579-41 -6.7-49 -7.9 71 41 47-24 -33.3 6 15.9 11.5 6.5 8.1 36 15 22-14 -38.9 7 43.4 Page 5 277 302 23 24 12/3Q 12/4Q 13/1Q 13/2Q 13/3Q 13/4Q 14/1Q 14/2Q 14/3Q 14/4Q 15/1Q
ビットリアカップ2007けいはんなサイクルレースリザルト
Page 4/30 Page 5/30 Page 6/30 Page 7/30 Page 8/30 Page 9/30 Page 10/30 Page 11/30 Page 12/30 Page 13/30 Page 14/30 Page 15/30 Page 16/30 Page 17/30 Page 18/30 Page 19/30 Page 20/30 Page 21/30 Page 22/30
i
14 i ii iii iv v vi 14 13 86 13 12 28 14 16 14 15 31 (1) 13 12 28 20 (2) (3) 2 (4) (5) 14 14 50 48 3 11 11 22 14 15 10 14 20 21 20 (1) 14 (2) 14 4 (3) (4) (5) 12 12 (6) 14 15 5 6 7 8 9 10 7
![かんたん操作ガイド[arrows M02]](/thumbs/39/20071242.jpg "かんたん操作ガイド[arrows M02]")
![かんたん操作ガイド[arrows RM02]](/thumbs/39/20475147.jpg "かんたん操作ガイド[arrows RM02]")
![かんたん操作ガイド[arrows M03]](/thumbs/42/22941141.jpg "かんたん操作ガイド[arrows M03]")
第１部 一般的コメント
(( 2000 11 24 2003 12 31 3122 94 2332 508 26 a () () i ii iii iv (i) (ii) (i) (ii) (iii) (iv) (a) (b)(c)(d) a) / (i) (ii) (iii) (iv) 1996 7 1996 12
第１章 国民年金における無年金
1 2 3 4 ILO ILO 5 i ii 6 7 8 9 10 ( ) 3 2 ( ) 3 2 2 2 11 20 60 12 1 2 3 4 5 6 7 8 9 10 11 12 13 13 14 15 16 17 14 15 8 16 2003 1 17 18 iii 19 iv 20 21 22 23 24 25 ,,, 26 27 28 29 30 (1) (2) (3) 31 1 20
2 English III Lecture Ready 1 Exploring Content 2 English IV Lecture Ready 1 Exploring Content 2 Microbiology II Chemistry of Biomolecules II Enzymology Biochemistry of Metabolism Physiology Plant Physiology
O157 6/23 7/4 6 25 1000 117,050 6 14:00~15:30 1 2 22 22 14:30~15:30 8 12 1 5 20 6 20 10 11 30 9 10 6 1 30 6 6 0 30 6 19 0 3 27 6 20 0 50 1 2 6 4 61 1 6 5 1 2 1 2 6 19 6 4 15 6 1 6 30 6 24 30 59
技能継承に関するアンケートの結果概要
I 1 1 1 1 1 1 2 1 3 1 II 2 1 2 2 2 3 2007 2 4 3 III 4 1 4 4 5 6 2 7 7 8 9 3 10 _10 11 _12 _13 _14 15 4 2007 16 2007 16 17 2007 18 5 19 19 I 2007 1 2005 6 21 8 3 3000 2 292 292 9.7 3 100 1 II 1 86 2 OJT
<4D F736F F D20342D D834F DA8E9F5F8AAE97B95F>
H. pylori S1-1 Hp S1-2 H. pylori S1-3 S1-4 75 Helicobacter pylori () S1-5 S1-6 Helicobacter pylori S1-7 H. pylori () S1-8 Helicobacter pylori () : H. pylori S2-1 H. pylori Ferric uptake regulator(fur)
宇治市役所システム監査事例報告
Copyright 2003 7 1 1... 1 1.1... 1 1.2... 2 1.2.1... 2 1.2.2... 3 2... 4 2.1... 4 2.1.1... 4 2.1.2... 5 2.1.3... 6 2.1.4... 7 2.1.5... 8 3... 9 3.1... 9 3.1.1... 9 3.1.2... 10 3.1.3... 11 3.1.4... 12 3.1.5...
untitled
2009518 9:109:20 A 9:2010:20 O-01 9:209:30 RNAODN CREST O-02 9:309:40 CREST O-03 9:409:50 NO O-04 9:5010:00 -- O-05 10:0010:10 闐闐 ERATO O-06 10:1010:20 DNA B 10:2011:20 O-07 10:2010:30 O-08 10:3010:40
活用ガイド （ソフトウェア編）
(Windows 95 ) ii iii iv NEC Corporation 1999 v P A R T 1 vi P A R T 2 vii P A R T 3 P A R T 4 viii P A R T 5 ix x P A R T 1 2 3 1 1 2 4 1 2 3 4 5 1 1 2 3 4 6 5 6 7 7 1 1 2 8 1 9 1 1 2 3 4 5 6 1 2 3 4
生体ナノテク第4回_穴なし
!!!!!!!!!!!! TEM! SEM, AFM! 参考文献 最先端材料システム One Point! イメージング (共立出版) 実験がうまくいく 蛍光 発光試薬の 選び方と使い方! (羊土社) 非侵襲 可視化 技術ハンドブック (NTS) 講義と実習 生細胞蛍光 イメージング (共立出版) よくわかる生物電子 顕微鏡技術 (共立出版) (in vivo) - /! - MRI! - X! in
077-089/fiñfi¡‰ž
49 2006 77 89 Nito Miyako 1402 81 1455 57 49 2006 1 49 2006 10 ii iii iii iii 11 12 13 14 ii 15 16 17 18 49 2006 19 20 21 22 23 24 49 2006 25 49 2006 26 27 28 29 1435 1511 30 31 1475 1550 32 49 2006 1739
provider_020524_2.PDF
1 1 1 2 2 3 (1) 3 (2) 4 (3) 6 7 7 (1) 8 (2) 21 26 27 27 27 28 31 32 32 36 1 1 2 2 (1) 3 3 4 45 (2) 6 7 5 (3) 6 7 8 (1) ii iii iv 8 * 9 10 11 9 12 10 13 14 15 11 16 17 12 13 18 19 20 (2) 14 21 22 23 24
「産業上利用することができる発明」の審査の運用指針（案）
1 1.... 2 1.1... 2 2.... 4 2.1... 4 3.... 6 4.... 6 1 1 29 1 29 1 1 1. 2 1 1.1 (1) (2) (3) 1 (4) 2 4 1 2 2 3 4 31 12 5 7 2.2 (5) ( a ) ( b ) 1 3 2 ( c ) (6) 2. 2.1 2.1 (1) 4 ( i ) ( ii ) ( iii ) ( iv)
Chapter13 Neural crest cells and axonal specificity 2
Chapter13 Neural crest cells and axonal specificity 1 Chapter13 Neural crest cells and axonal specificity 2 Chapter13 Neural crest cells and axonal specificity 3 Chapter13 Neural crest cells and axonal
< > Introduction to Basic Physical Chemistry 1,2 2 [ advanced [ [ [ [ [ KULASIS
< > Introduction to Basic Organic Chemistry 1,2 [ 2 [ 10 11 12 13 14 15 [ [ [ [ KULASIS < > Introduction to Basic Physical Chemistry 1,2 2 [ advanced [ 11 12 14 15 [ [ [ [ KULASIS < > Introduction to Basic
i ii iii iv v vi vii ( ー ー ) ( ) ( ) ( ) ( ) ー ( ) ( ) ー ー ( ) ( ) ( ) ( ) ( ) 13 202 24122783 3622316 (1) (2) (3) (4) 2483 (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) 11 11 2483 13
...iii...iv...v...vi 1.1... 1-1 1.2... 1-1 1.3... 1-2 1.4... 1-3 1.4.1... 1-3 1.4.2 Auto-Rotate ()... 1-4 1.4.3 AI Light (AI )... 1-4 2.1... 2-1 2.2 U
MB168B/MB168B+ USB ...iii...iv...v...vi 1.1... 1-1 1.2... 1-1 1.3... 1-2 1.4... 1-3 1.4.1... 1-3 1.4.2 Auto-Rotate ()... 1-4 1.4.3 AI Light (AI )... 1-4 2.1... 2-1 2.2 USB... 2-2 2.3... 2-3 3.1... 3-1
2
Caenorhabditis elegans 2 3 4 5 6 AFD AWA, AWB, AWC ADF, ADL ASI, ASJ ASK, ASE ASG, ASH 7 1.0 1.0 0.8 0.8 0.6 0.6 0.4 0.4 0.2 0.2 0-0.2 0 0.03 0.1 0.3 0.5 0.7 1.0 3.0 Na concentration (mol/l) -0.4 0.001
C 1) 2) 3) 4) 5) 6) 7) 8) 9)
130603 (1-3) C 1) 2) 3) 4) 5) 6) 7) 8) 9) C 1) 2) 3) DNA 4) DNA RNA 5) 6) PCR 7) DNA C Cyclops Odlilon Redon, The Cyclops, 1914 WAGR www.wagr.org WAGR www.wagr.org Cell 126, 663-676, 2006 Wikipedia
cm H.11.3 P.13 2 3-106-
H11.3 H.11.3 P.4-105- cm H.11.3 P.13 2 3-106- 2 H.11.3 P.47 H.11.3 P.27 i vl1 vl2-107- 3 h vl l1 l2 1 2 0 ii H.11.3 P.49 2 iii i 2 vl1 vl2-108- H.11.3 P.50 ii 2 H.11.3 P.52 cm -109- H.11.3 P.44 S S H.11.3
活用ガイド （ソフトウェア編）
(Windows 98 ) ii iii iv v NEC Corporation 1999 vi P A R T 1 P A R T 2 vii P A R T 3 viii P A R T 4 ix P A R T 5 x P A R T 1 2 3 1 1 2 4 1 2 3 4 5 1 1 2 3 4 5 6 6 7 7 1 1 2 8 1 9 1 1 2 3 4 5 6 1 2 3 10
< B C957491E48E86312E696E6464>
10 DDS New York Academy Renal Biochemistry (Elsevier) Glutathione (John Wiley & Sons) Antioxidants in Therapy and Preventive Medicine (Plenum) The Liver: Biology and Pathophysiology (Raven Press) NO SSC
VITAMIN85-12(高解像度).pdf
Vol. 85 2011 23 12 12 2011 85 12 12 2011 85 1 2 D 47 11 E 595 1 2 1 1 D K 9 2 B 57 3 CYP105A1 D3 109 5 6 K 271 9 E 463 10 E 531 10 Pdc2 538 11 587 12 631 8 383 8 385 8 387 8 389 8 C 400 8 405 8 408 8